Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 7/20 | 0.54 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28460070 | 0.76 | GRM5 (0.54) | GRM5GSK3BKDM4EALDH1A1NPC1 | |
| SCHEMBL613587 | 0.75 | KDM4E (0.42) | GRM5GSK3BKDM4EALDH1A1HPGD | |
| SCHEMBL9489040 | 0.75 | GSK3B (0.46) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL2807773 | 0.75 | GSK3B (0.46) | GRM5GSK3BKDM4EALDH1A1HPGD | |
| SCHEMBL108548 | 0.75 | ALOX15 (0.43) | GRM5KDM4EALDH1A1NPC1HPGD | |
| SCHEMBL29546502 | 0.75 | ALOX15 (0.43) | GRM5KDM4EALDH1A1NPC1HPGD | |
| SCHEMBL29704524 | 0.74 | GSK3B (0.45) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL29367243 | 0.73 | KDM4E (0.40) | GRM5GSK3BKDM4EALDH1A1HPGD | |
| SCHEMBL16754925 | 0.71 | GSK3B (0.62) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL1666085 | 0.71 | APP (0.63) | GRM5KDM4EALDH1A1NPC1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5567800-A | MOLECULAR WEIGHT CONTROLLED AROMATIC POLYIMIDES; ELONGATION, HIGH GLASS TRANSITION TEMPERATURE, TOUGHNESS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1996-10-22 | — | — | US | claimed |
| EP-2990431-B1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | BOEING CO (US) | 2024-03-27 | — | — | EP | disclosed |
| EP-4332169-A2 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | The Boeing Company (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-110204716-A | Polyimide oligomers and resin system | 波音公司 | 2019-09-06 | — | — | CN | disclosed |
| CN-105384932-B | Nano-modified backbone of polyimides with difunctional and mixed-functional endcaps | 波音公司 | 2019-06-04 | — | — | CN | disclosed |
| US-9670325-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9505864-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-9464171-B2 | Peripherally aromatic silsesquioxanes featuring reactive functionality: synthesis and application thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2016-10-11 | — | — | US | disclosed |
| US-20160208053-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-07-21 | — | — | US | disclosed |
| US-9315633-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| US-8981140-B1 | Peripherally aromatic silsesquioxanes featuring reactive functionality: synthesis and applications thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2015-03-17 | — | — | US | disclosed |
| US-20100059261-A1 | REACTIVE MONOMER AND RESIN COMPOSITION CONTAINING SAME | AMT LABORATORY CO., LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-1018507-B1 | Terminal-modified imide oligomers and cured products thereof | UBE INDUSTRIES (JP) | 2004-10-06 | — | — | EP | disclosed |
| EP-0966493-A4 | REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS | COMMW SCIENT IND RES ORG (AU) | 2004-04-21 | — | — | EP | disclosed |
| US-6344523-B1 | POLYIMIDES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION OF CAMPBELL (AU) | 2002-02-05 | — | — | US | disclosed |
| EP-0966493-A1 | REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998040422-A1 | REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-09-17 | — | — | WO | disclosed |
| US-5760168-A | CONTROLLED MOLECULAR WEIGHT; FILMS, MOLDINGS, ADHESIVES, COMPOSITES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AEUONAUTICS AND SPACE ADMINISTRATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5681967-A | ENDCAPPING POLYAMIC ACIDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1997-10-28 | — | — | US | disclosed |
| US-5567800-A | MOLECULAR WEIGHT CONTROLLED AROMATIC POLYIMIDES; ELONGATION, HIGH GLASS TRANSITION TEMPERATURE, TOUGHNESS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1996-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100059261-A1 | REACTIVE MONOMER AND RESIN COMPOSITION CONTAINING SAME | RAD51, ACTR2, ARID2 | GRM5 893/4885GSK3B 4595/4885KDM4E 3785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.